Longer ICU stay and invasive mechanical ventilation accelerate telomere shortening in COVID-19 patients 1 year after recovery
- PMID: 39113075
- PMCID: PMC11308640
- DOI: 10.1186/s13054-024-05051-6
Longer ICU stay and invasive mechanical ventilation accelerate telomere shortening in COVID-19 patients 1 year after recovery
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes virus-induced-senescence. There is an association between shorter telomere length (TL) in coronavirus disease 2019 (COVID-19) patients and hospitalization, severity, or even death. However, it remains unknown whether virus-induced-senescence is reversible. We aim to evaluate the dynamics of TL in COVID-19 patients 1 year after recovery from intensive care units (ICU). Longitudinal study enrolling 49 patients admitted to ICU due to COVID-19 (August 2020 to April 2021). Relative telomere length (RTL) quantification was carried out in whole blood by monochromatic multiplex real-time quantitative PCR (MMqPCR) assay at hospitalization (baseline) and 1 year after discharge (1-year visit). The association between RTL and ICU length of stay (LOS), invasive mechanical ventilation (IMV), prone position, and pulmonary fibrosis development at 1-year visit was evaluated. The median age was 60 years, 71.4% were males, median ICU-LOS was 12 days, 73.5% required IMV, and 38.8% required a prone position. Patients with longer ICU-LOS or who required IMV showed greater RTL shortening during follow-up. Patients who required pronation had a greater RTL shortening during follow-up. IMV patients who developed pulmonary fibrosis showed greater RTL reduction and shorter RTL at the 1-year visit. Patients with longer ICU-LOS and those who required IMV had a shorter RTL in peripheral blood, as observed 1 year after hospital discharge. Additionally, patients who required IMV and developed pulmonary fibrosis had greater telomere shortening, showing shorter telomeres at the 1-year visit. These patients may be more prone to develop cellular senescence and lung-related complications; therefore, closer monitoring may be needed.
Keywords: ARDS; COVID-19; ICU; IMV; Relative telomere length; SARS-CoV2.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Health outcomes and economic burden among patients with a COVID-19-associated hospitalization in the United States during the predominance of the XBB and JN.1 omicron lineages.J Med Econ. 2024 Jan-Dec;27(1):1372-1378. doi: 10.1080/13696998.2024.2416873. Epub 2024 Oct 26. J Med Econ. 2024. PMID: 39429025
-
Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.Neuropeptides. 2021 Dec;90:102201. doi: 10.1016/j.npep.2021.102201. Epub 2021 Oct 1. Neuropeptides. 2021. PMID: 34753072 Free PMC article.
-
Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study.Front Cell Infect Microbiol. 2025 Jan 8;14:1489936. doi: 10.3389/fcimb.2024.1489936. eCollection 2024. Front Cell Infect Microbiol. 2025. PMID: 39844842 Free PMC article.
-
COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis.PLoS One. 2021 Feb 11;16(2):e0246318. doi: 10.1371/journal.pone.0246318. eCollection 2021. PLoS One. 2021. PMID: 33571301 Free PMC article.
-
Obesity in patients with COVID-19: a systematic review and meta-analysis.Metabolism. 2020 Dec;113:154378. doi: 10.1016/j.metabol.2020.154378. Epub 2020 Sep 28. Metabolism. 2020. PMID: 33002478 Free PMC article.
Cited by
-
Neurotropic Viruses as Acute and Insidious Drivers of Aging.Biomolecules. 2025 Apr 1;15(4):514. doi: 10.3390/biom15040514. Biomolecules. 2025. PMID: 40305226 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous